DIAGNOS (CVE:ADK) Trading Up 15.8% – Should You Buy?

DIAGNOS Inc. (CVE:ADKGet Free Report) shares shot up 15.8% on Tuesday . The company traded as high as C$0.24 and last traded at C$0.22. 914,922 shares were traded during mid-day trading, an increase of 350% from the average session volume of 203,422 shares. The stock had previously closed at C$0.19.

DIAGNOS Trading Up 15.8%

The company has a market capitalization of C$22.41 million, a price-to-earnings ratio of -4.40 and a beta of 0.17. The company has a debt-to-equity ratio of 133.68, a quick ratio of 0.68 and a current ratio of 1.75. The firm has a fifty day moving average price of C$0.24 and a 200-day moving average price of C$0.29.

DIAGNOS Company Profile

(Get Free Report)

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.

See Also

Receive News & Ratings for DIAGNOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIAGNOS and related companies with MarketBeat.com's FREE daily email newsletter.